CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
12 hedge funds and large institutions have $19.3M invested in Celyad Oncology SA American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$913K | |
| 2 | +$452K | |
| 3 | +$147K | |
| 4 |
Morgan Stanley
New York
|
+$43.5K |
| 5 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
+$32.5K |
Top Sellers
| 1 | -$382K | |
| 2 | -$205K | |
| 3 | -$7.31K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$158 |